Oral Difelikefalin Reduces Pruritus in Atopic Dermatitis

Main Article Content

Brian Kim
Masato Tamari
Lydia Zamidar
Kristine Nograles
Catherine Munera
Joana Goncalves
Emma Guttman-Yassky
Mark Lebwohl

Keywords

difelikefalin, pruritis, atopic dermatitis

Abstract

N/A

References

1. Weidinger S, et al. Nat Rev Dis Primers. 2018;4:1.

2. Huet F, et al. Acta Derm Venereol. 2019;99:279- 283.

3. Fishbane S, et al. N Engl J Med. 2020;382:222-232.

4. Wooldridge T, et al. Efficacy and Safety of Difelikefalin for Moderate-to-Severe Chronic Kidney Disease–Associated Pruritus: a Global Phase 3 Study in Hemodialysis Patients (KALM-2). Presented at: Annual Meeting of the American Society of Nephrology; October 20-25, 2020.

5. Korsuva [package insert]. Stamford, CT: Cara Therapeutics, Inc.; August 2021.

6. Moosbrugger-Martinz V, et al. Methods Mol Biol. 2017;1559:91-106.

7. Oetjen LK, et al. Cell. 2017;171:217-228. 8. Usoskin D, et al. Nat Neurosci. 2015;18:145-153.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>